KONG Lujiao,LU Hua,WANG Xin,et al.Protective effect and mechanism of quercetin on cardiac and renal functions in rats with cardiorenal syndrome[J].ZHONGGUO YAOFANG,2024,35(13):1612-1617.
KONG Lujiao,LU Hua,WANG Xin,et al.Protective effect and mechanism of quercetin on cardiac and renal functions in rats with cardiorenal syndrome[J].ZHONGGUO YAOFANG,2024,35(13):1612-1617.DOI: 10.6039/j.issn.1001-0408.2024.13.12.
Protective effect and mechanism of quercetin on cardiac and renal functions in rats with cardiorenal syndrome
To investigate the protective effect and mechanism of quercetin on the cardiac and renal functions of rats with cardiorenal syndrome (CRS) based on the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/nuclear factor kappa-B (NF-κB) signaling pathway.
METHODS
2
CRS model of SD rats was induced by left anterior descending coronary artery ligation combined with acute renal ischemia-reperfusion. Model rats were randomly separated into model group, quercetin low-dose group (35 mg/kg), quercetin high-dose group (70 mg/kg), high-dose of quercetin+740Y-P group (70 mg/kg quercetin+3.5 mg/kg PI3K/Akt/NF-κB signaling pathway activator 740Y-P), with 12 rats in each group. Another 12 normal rats were selected as sham operation group. They were given relevant drugs, once a day, for 14 consecutive days. After administration, the cardiac function indexes [left ventricular ejection fraction (LVEF), end-diastolic volume (EDV), isovolumic relaxation time (IVRT)] and renal function indicators [blood urea nitrogen (BUN), 24-hour urine protein, and serum creatinine (Scr)] were detected, and fibrosis in the cardiac and renal tissues was observed; the levels of inflammatory indexes [interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α)] in the serum and cardiac and renal tissues as well as the expression of PI3K/Akt/NF-κB pathway-related proteins in the cardiac and renal tissues were detected.
RESULTS
2
Compared with sham operation group, the levels of BUN, 24-hour urine protein and Scr, collagen volume fraction of cardiac and renal tissues, the levels of IL-1β and TNF-α in serum and cardiac and renal tissues, and the phosphorylation of PI3K, Akt and NF-κB p65 protein in cardiac and renal tissues were increased significantly in model grou
p (
P
<0.05); the levels of LVEF, IVRT and EDV were reduced significantly (
P
<0.05). Compared with the model group, the above indexes were reversed significantly in quercetin low-dose and high-dose groups (
P
<0.05), and the reversal effect was better in the high-dose group (
P
<0.05). 740Y-P restored the reverse effect of high-dose quercetin on the indexes (
P
<0.05).
CONCLUSIONS
2
Quercetin can alleviate cardiac and renal fibrosis and function injury, the mechanism of which may be associated with inhibiting the activation of the PI3K/Akt/NF-κB signaling pathway.
关键词
Keywords
references
MCCALLUM W , SARNAK M J . Cardiorenal syndrome in the hospital [J ] . Clin J Am Soc Nephrol , 2023 , 18 ( 7 ): 933 - 945 .
MCCALLUM W , TESTANI J M . Updates in cardiorenal syndrome [J ] . Med Clin North Am , 2023 , 107 ( 4 ): 763 - 780 .
COSTANZO M R . The cardiorenal syndrome in heart failure [J ] . Cardiol Clin , 2022 , 40 ( 2 ): 219 - 235 .
AMADOR-MARTÍNEZ I , APARICIO-TREJO O E , BERNABE-YEPES B , et al . Mitochondrial impairment:a link for inflammatory responses activation in the cardiorenal syndrome type 4 [J ] . Int J Mol Sci , 2023 , 24 ( 21 ): 15875 .
LIU J , ZONG C G , YU X , et al . Alanyl-glutamine (Ala-gln) ameliorates dextran sulfate sodium (DSS)-induced acute colitis by regulating the gut microbiota,PI3K-Akt/NF-κB/STAT3 signaling,and associated pulmonary injury [J ] . ACS Infect Dis , 2023 , 9 ( 4 ): 979 - 992 .
CHEN K T , HUANG X X , XIE D X , et al . RNA interactions in right ventricular dysfunction induced type Ⅱ cardiorenal syndrome [J ] . Aging , 2021 , 13 ( 3 ): 4215 - 4241 .
WANG Y Y , LIU Y Y , LI J , et al . Gualou xiebai decoction ameliorates cardiorenal syndrome type Ⅱ by regulation of PI3K/Akt/NF-κB signaling pathway [J ] . Phytomedicine , 2024 , 123 : 155172 .
SITI H N , JALIL J , ASMADI A Y , et al . Effects of quercetin on cardiac function in pressure overload and postische-mic cardiac injury in rodents:a systematic review and meta-analysis [J ] . Cardiovasc Drugs Ther , 2022 , 36 ( 1 ): 15 - 29 .
FENG Q , YANG Y , QIAO Y J , et al . Quercetin ameliorates diabetic kidney injury by inhibiting ferroptosis via activating Nrf2/HO-1 signaling pathway [J ] . Am J Chin Med , 2023 , 51 ( 4 ): 997 - 1018 .
BAGHERI A , RADMAN G , ARIA N , et al . The effects of quercetin on apoptosis and antioxidant activity in a renal ischemia/reperfusion injury animal model [J ] . Drug Res , 2023 , 73 ( 5 ): 255 - 262 .
WANG S G , LIU P , REN C , et al . Protective effect of astragaloside Ⅳ on renal function in rats with cardiorenal syndrome [J ] . Chin J Clin Pharmacol , 2023 , 39 ( 3 ): 363 - 367 .
JIANG C J , LI D , CHEN L , et al . Quercetin ameliorated cardiac injury via reducing inflammatory actions and the glycerophospholipid metabolism dysregulation in a diabetic cardiomyopathy mouse model [J ] . Food Funct , 2022 , 13 ( 14 ): 7847 - 7856 .
WANG W M , TIAN T . The correlation between PI3K/Akt pathway and insulin resistance in cardiomyocytes of rat models of hyperthyroidism [J ] . Guangdong Med J , 2020 , 41 ( 24 ): 2526 - 2530 .
WU Y Z , LI Z L , LAI J , et al . AtractylenolideⅠ protects cardiac and renal function of rats with cardiorenal syndrome via suppressing fibrosis synthesis [J ] . Mod J Integr Tradit Chin West Med , 2023 , 32 ( 20 ): 2788 - 2797 .
GALLO G , LANZA O , SAVOIA C . New insight in cardiorenal syndrome:from biomarkers to therapy [J ] . Int J Mol Sci , 2023 , 24 ( 6 ): 5089 .
GEORGOPOULOU T , PETRAKIS I , DERMITZAKI K , et al . Cardiorenal syndrome:challenges in everyday clinical practice and key points towards a better management [J ] . J Clin Med , 2023 , 12 ( 12 ): 4121 .
LUO M , LIU Z Y , HU Z R , et al . Quercetin improves contrast-induced acute kidney injury through the HIF-1α/lncRNA NEAT1/HMGB1 pathway [J ] . Pharm Biol , 2022 , 60 ( 1 ): 889 - 898 .
POVEDA J , VÁZQUEZ-SÁNCHEZ S , SANZ A B , et al . TWEAK-Fn14 as a common pathway in the heart and the kidneys in cardiorenal syndrome [J ] . J Pathol , 2021 , 254 ( 1 ): 5 - 19 .
DU L , ZHANG J R , ZHANG X Y , et al . Oxypeucedanin relieves LPS-induced acute lung injury by inhibiting the inflammation and maintaining the integrity of the lung air-blood barrier [J ] . Aging , 2022 , 14 ( 16 ): 6626 - 6641 .
TSUKAMOTO S , WAKUI H , UEHARA T , et al . Combination of sacubitril/valsartan and blockade of the PI3K pathway enhanced kidney protection in a mouse model of cardiorenal syndrome [J ] . Eur Heart J Open , 2023 , 3 ( 6 ): oead098 .